Clinical Trial

Velocity-Based Resistance Training in Kidney Transplant Recipients

Study acronym: VBRTKIDNEY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to evaluate the effects of velocity-based resistance training on renal function and metabolic health in kidney transplant recipients. Participants will be randomized into two groups performing resistance training at different execution velocities (maximal intended vs. submaximal controlled). The intervention will last 12 weeks and include multi-joint exercises (squat, bench press, military press). Primary outcomes include renal function (serum creatinine, eGFR, blood urea nitrogen, uric acid) and metabolic markers (HDL, triglycerides, glucose, waist circumference, blood pressure). Secondary outcomes include muscle strength, force-velocity profile, anthropometry, physical activity, fitness perception, and adherence to immunosuppressive medication.
Trial Details
NCT Number NCT07370727
Lead Sponsor Fundación Universitaria del Area Andina
Conditions Kidney Transplant Recipients, Metabolic Syndrome, Cardiovascular Risk Factors
Enrollment 12 participants
Start Date 2025-10-29
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27